Sign in

CIK 0001348362

  • Non-accelerated filer
  • Smaller reporting company

Lexaria Bioscience Corp.

Sign in to watch
Ticker
LEXX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Aug 31
Incorporated
NV
Entity type
Operating
EIN
202000871
Phone
+1 250-765-6424
Business address
100 - 740 MCCURDY ROAD, KELOWNA, British Columbia, Canada, V1X 2P7
Former names
Lexaria Corp., LEXARIA CORP.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market buy Director bought 1,500 shares at $2.84 ($4,267)
  4. 4/A Open-market buy Chief Financial Officer bought 121 shares at $2.09 ($253)
  5. 4/A Open-market buy Chief Executive Officer bought 38,500 shares at an average $2.04 ($78,397)
  6. 4 Grant or award Chief Financial Officer acquired 121 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Grant or award CEO acquired 38,500 shares (grant or award)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Grant or award Director acquired 5,000 shares (grant or award)
  19. 4 Grant or award Director acquired 1,799 shares (grant or award)
  20. 4 Grant or award Director acquired 3,201 shares (grant or award)

Page 3 of 21 · 420 filings